Spinal cord compression is an uncommon but important complication of metastasis from solid tumours which causes considerable morbidity. Lung cancer is the most common primary tumour in such patients, accounting for 20-30% of cases (Stark et al., 1982; Brice & McKissock, 1965; Young et al., 1980; Dunn et al., 1980; Marshall & Langfitt, 1977) , with 25% histologically of small cell type (Stark et al., 1982) . The incidence of spinal cord compression in patients with small cell lung cancer (SCLC) is estimated at between 3.5 and 13% (Pedersen et al., 1985; Posner, 1977; Nugent et al., 1979) . Treatment is often unsatisfactory, with many patients remaining seriously disabled throughout the illness (Stark et al., 1982; Young et al., 1980; Dunn et al., 1980; Marshall & Langfitt, 1977; Pedersen et al., 1985; Posner, 1977; Nugent et al., 1979; Rodriguez & Dinapoli, 1980) . Prevention of this complication is highly desirable and recognition of patients at high risk of cord compression could allow early prophylactic treatment with radiotherapy. We performed an analysis of 610 patients with SCLC, treated in a single randomised trial, with the aim of defining the incidence, clinical features, predictive factors and prognosis of spinal cord compression.
Patients and methods
Six-hundred and sixteen previously untreated patients were entered in a multicentre trial of chemotherapy for SCLC between February 1982 and September 1986 (Spiro et al., 1987 Five hundred patients in the whole trial had bone scans performed at presentation. Two hundred and thirty-four (47%) showed abnormal uptake of isotope by bone, and in 131 (26%) this included the spinal column and was suggestive of metastatic disease. The cervical spine alone was affected in 17 cases, the thoracic or thoracic and lumbar spine in 61 cases and the lumbo-sacral spine alone in 43 cases. Fourteen patients had positive bone scans at relapse, nine involving the spinal column.
Of the 24 cases of spinal cord compression (Table I ) nine (37.5%) had positive bone scans at presentation with abnormal isotope uptake in the spinal column. In all of these the abnormality was located in the thoracic spine. Two other Eleven (45%) of the 24 patients with spinal cord compression had cerebral metastases, four before the onset of cord compression and seven after the development of their spinal symptoms (Table I ). In the multicentre trial 32 patients presented with cerebral metastases and a further 87 went on to develop them, the overall incidence being 19.5%.
The 24 patients with spinal cord compression could be divided into two groups (Table I) were treated symptomatically and had a median survival of four weeks (range 1-14 weeks).
Discussion
The incidence of spinal cord compression in patients with SCLC in this study was 4%, which is similar to that reported in previous retrospective series (Pedersen et al., 1985; Nugent et al., 1979) . Only six of the 24 patients who developed cord compression regained ambulance and continence and median survival from onset of the syndrome was 6 weeks.
We analysed the results of the 500 initial bone scans performed in the trial in order to assess if a positive bone scan affecting the spinal column at presentation was a useful predictive factor for spinal cord compression (Table IV) . Twenty-six per cent of these scans showed increased isotope uptake in the spine, suggesting metastases. Within this group nine patients (7%) went on to develop cord compression. A positive bone scan affecting the spine is thus not a strong enough predictor of cord compression to merit prophylactic radiotherapy. However, if pain is also taken into account, of the 24 patients presenting with back pain and a positive bone scan affecting the spine, nine (36%) developed cord compression. In eight of these patients the site of cord compression coincided with the site of the abnormality on the bone scan. In current practice, however, isotope bone scans are used less frequently in the staging of SCLC, but our data would suggest that they should be undertaken in patients with back pain. This would allow the identification of patients with vertebral metastases who may be at risk of spinal cord compression and indicate the area to which prophylactic radiotherapy might be directed, in the hope of preventing cord compression as the fully established syndrome responds disappointingly to therapy.
Cerebral metastases occurred in 46% of patients with spinal cord compression and in 19.5% of the patients in the trial, confirming the association between metastases from SCLC in different parts of the central nervous system (Nugent et al., 1979; Rosen et al., 1982) . There were 24 patients who had positive bone scans affecting the spine and cerebral metastases, six (25%) developed spinal cord compression at the site of abnormal isotope uptake. These risk factors in combination may also merit treatment with radiotherapy to the spine at the level of the abnormality as prophylaxis against spinal cord compression. The 24 patients with spinal cord compression in this series could be divided into two distinct groups with differing clinical features and prognosis. Group A, who presented with cord compression, all had back pain and positive bone scans or abnormal X-rays affecting the spine. By contrast in group B, who had relapsed with cord compression, less than half had back pain and only a quarter had evidence of bone destruction using the imaging techniques. In group A three of the four myelograms performed showed a complete block, while in group B, of the seven myelograms performed four showed a partial block, one an intra-medullary metastasis and one a complete block.
The overall median survival of patients in group A was 30 weeks and in group B 34 weeks (Figure 1 ). However, if survival is measured from onset of cord compression the two groups are very different. Group A patients have the same median survival (30 weeks) while that of group B is 4 weeks. This poor prognosis in association with the severe morbidity of the condition leads us to consider the use of prophylactic radiotherapy to the area of increased isotope uptake in those who present with back pain and a positive bone scan, and in those with evidence of cerebral metastases and a positive bone scan. The aim of this intervention would be to decrease the incidence of spinal cord compression.
